Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $648,897 (100.0% shares, 0.0% debt)

Holdings (9)

IRWD IRONWOOD PHARMACEUTICALS INC 28.9%

Value ($000) $187,502 Shares 16,390,000 Est. Cost $11.52 Unrealized -14.1%

BIIB BIOGEN INC 25.6%

Value ($000) $166,389 Shares 643,000 Est. Cost $278.12 Unrealized -11.7%

INVA INNOVIVA INC 18.0%

Value ($000) $116,723 Shares 7,277,000 Est. Cost $13.02 Unrealized +7.4%

GILD GILEAD SCIENCES INC 13.4%

Value ($000) $87,118 Shares 1,075,400 Est. Cost $57.76 Unrealized +25.0%

NBIX NEUROCRINE BIOSCIENCES INC 9.5%

Value ($000) $61,927 Shares 470,000 Est. Cost $103.73 Unrealized +11.0%

— AMARIN CORP PLC 3.3%

Value ($000) $21,620 Shares 24,850,623 Est. Cost $1.48 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 0.9%

Value ($000) $5,990 Shares 1,000,000 Est. Cost $5.06 Unrealized +14.6%

— VOR BIOPHARMA INC 0.2%

Value ($000) $1,391 Shares 618,000 Est. Cost $43.10 Unrealized —

— REGULUS THERAPEUTICS INC 0.0%

Value ($000) $237 Shares 185,183 Est. Cost $2.07 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$187,502	28.9%	$11.52	-14.1%	COM CL A	46333X108
BIIB	BIOGEN INC	643,000	$166,389	25.6%	$278.12	-11.7%	COM	09062X103
INVA	INNOVIVA INC	7,277,000	$116,723	18.0%	$13.02	+7.4%	COM	45781M101
GILD	GILEAD SCIENCES INC	1,075,400	$87,118	13.4%	$57.76	+25.0%	COM	375558103
NBIX	NEUROCRINE BIOSCIENCES INC	470,000	$61,927	9.5%	$103.73	+11.0%	COM	64125C109
—	AMARIN CORP PLC	24,850,623	$21,620	3.3%	$1.48	—	SPONS ADR NEW	023111206
BCRX	BIOCRYST PHARMACEUTICALS INC	1,000,000	$5,990	0.9%	$5.06	+14.6%	COM	09058V103
—	VOR BIOPHARMA INC	618,000	$1,391	0.2%	$43.10	—	COM	929033108
—	REGULUS THERAPEUTICS INC	185,183	$237	0.0%	$2.07	—	COM	75915K309